Spero Therapeutics
SPRO
#9124
Rank
C$90.71 M
Marketcap
$1.66
Share price
-0.83%
Change (1 day)
0.37%
Change (1 year)

Earnings for Spero Therapeutics (SPRO)

Earnings in 2024 (TTM): C$22.02 Million

According to Spero Therapeutics's latest financial reports the company's current earnings are C$0.10 Billion. In 2023 the company made an earning of C$32.81 Million, an increase over its 2022 earnings that were of -C$61.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spero Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$22.02 M-32.88%
2023 C$32.81 M-153.57%
2022 -C$61.26 Million-50.14%
2021 -C$0.13 Billion11.06%
2020 -C$0.12 Billion25.15%
2019 -C$88.4 Million47.68%
2018 -C$59.86 Million5.61%
2017 -C$56.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$35.65 M 45.37%๐Ÿ‡บ๐Ÿ‡ธ USA
C$8.73 B 35,530.81%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.59 B 10,480.92%๐Ÿ‡จ๐Ÿ‡ฆ Canada